Recruiting Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice: NCT06322238 Conditions Drug Metabolism, Poor, CYP2C19-Related, Drug Metabolism, Poor, CYP2D6-Related, Ineffective Drug Action, +2 more Locations Mayo Clinic — Rochester, Minnesota, United States View Trial Details
Completed Pharmacogenetic Testing Among Home Health Patients NCT02378220 Conditions Adverse Drug Events, Adverse Drug Reactions, Chemically-Induced Disorders, +12 more Locations White County Medical Center Home Health — Searcy, Arkansas, United States View Trial Details
Completed YouScript IMPACT Registry NCT02191358 Conditions Adverse Drug Events, Adverse Drug Reactions, Chemically-Induced Disorders, +13 more Locations Dr. Michael Dao — Garden Grove, California, United States Kaiser Permanente Colorado — Denver, Colorado, United States Gill Heart Institute — Lexington, Kentucky, United States IRC Clinics — Towson, Maryland, United States View more locations Show fewer locations Loading locations... View Trial Details
Completed Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM NCT02428660 Conditions CYP2D6 Polymorphism, Chemically-Induced Disorders, Chronic Disease, +12 more Locations VRx Pharmacy Services — Salt Lake City, Utah, United States View Trial Details
